CanSino’s Ebola Vaccine Manufacturing Facility, Tianjin

Tianjin CanSino Biotechnology (CanSino) began construction of its first-fully integrated Ebola vaccine manufacturing facility at Tianjin Economic-Technological Development Area (TEDA) west zone in China, in October 2015.
Source: Pharmaceutical Technology - Category: Pharmaceuticals Source Type: news